Full Coverage

AVEO Pharmaceuticals Granted Patent For Unique Genetic Screen To Identify Novel Cancer Drug Targets

                   
medicalnewstoday.com
May 26, 2008
        
Story Timeline:  193 days

AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, tannounced that on May 13, 2008, the United States Patent and Trademark Office granted U.S. Patent No. [read full story]                    

Add Comment
Latest article on this story:

US AVEO Pharmaceuticals Granted Patent For Unique Genetic Screen To Identify Novel Cancer Drug...

 pharmiweb.co.uk May 27, 2008
First article on this story:

US AVEO Pharmaceuticals Granted Patent For Unique Genetic Screen To Identify Novel Cancer Drug...

 pharmiweb.co.uk May 27, 2008
Selected publications with coverage of this story:
medicalnewstoday.com pharmiweb.co.uk
RELATED
No documents found.